Isolation of Mycobacterium tuberculosis strains with a silent mutation in rpoB leading to potential misassignment of resistance category

Journal of Clinical Microbiology

Volumn 49, Issue 7, 2011, Pages 2688-2690

  Alonso, María ^a,b   Palacios, Juan José ^c   Herranz, Marta ^a,b   Penedo, Ana ^c   Menéndez, Ángela ^c   Bouza, Emilio ^a,b   García De Viedma, Darío ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CODON; CONTROLLED STUDY; HYBRIDIZATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AMINO ACID SUBSTITUTION; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DIAGNOSTIC ERRORS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID HYBRIDIZATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RIFAMPIN;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79959841096     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00659-11     Document Type: Article

References (15)

1. Alito, A., et al. 1999. The IS6110 restriction fragment length polymorphism in particular multidrug-resistant Mycobacterium tuberculosis strains may evolve too fast for reliable use in outbreak investigation. J. Clin. Microbiol. 37:788-791.
2. Barnard, M., H. Albert, G. Coetzee, R. O'Brien, and M. E. Bosman. 2008. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177:787-792.
3. Brudey, K., et al. 2006. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol. 6:23-39.
4. Bwanga, F., S. Hoffner, M. Haile, and M. L. Joloba. 2009. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect. Dis. 9:67-81.
5. Casas-Fisher, R., A. Penedo-Pallares, J. J. Palacios-Gutiérrez, and A. Moreno-Torrico. 30 May 2011, posting date. Outbreak or coincidental cases of tuberculosis? Genotyping gives the clue. Am. J. Infect. Control. doi:10.1016/j.ajic.2011.03.003.
6. Cave, M. D., et al. 2005. Epidemiologic import of tuberculosis cases whose isolates have similar but not identical IS6110 restriction fragment length polymorphism patterns. J. Clin. Microbiol. 43:1228-1233.
7. Dos Vultos, T., et al. 2008. Evolution and diversity of clonal bacteria: the paradigm of Mycobacterium tuberculosis. PLoS One 3:e1538-e1547.
8. Ebrahimi-Rad, M., et al. 2003. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg. Infect. Dis. 9:838-845.
9. Glynn, J. R., et al. 2004. DNA fingerprint changes in tuberculosis: reinfection, evolution, or laboratory error? J. Infect. Dis. 190:1158-1166.
10. Kapur, V., et al. 1994. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 32:1095-1098.
11. Morgan, M., S. Kalantri, L. Flores, and M. Pai. 2005. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect. Dis. 5:62-70.
12. Perri, B. R., et al. 2011. Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, U.S.A., 2003-2009. Emerg. Infect. Dis. 17:372-378.
13. Schurch, A. C., et al. 2011. Preferential deletion events in the direct repeat locus of Mycobacterium tuberculosis. J. Clin. Microbiol. 49:1318-1322.
14. Schurch, A. C., et al. 2010. The tempo and mode of molecular evolution of Mycobacterium tuberculosis at patient-to-patient scale. Infect. Genet. Evol. 10:108-114.
15. Woods, G. L. 2003. Susceptibility testing of mycobacteria, nocardiae and other aerobic actinomycetes: approved standard. National Committee for Clinical Laboratory Standards, Wayne, PA.